Excipients in Pharmaceuticals: Global Markets to 2029
상품코드:1563137
리서치사:BCC Research
발행일:2024년 09월
페이지 정보:영문 105 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 의약품 부형제 시장 규모는 2023년 92억 달러, 2024년 97억 달러에서 예측 기간 동안 연평균 5.1% 성장하여 2029년 말에는 124억 달러에 달할 것으로 예상됩니다.
유기 부형제 부문은 2024년 87억 달러에서 5.2%의 CAGR로 2029년 말에는 112억 달러로 성장할 것으로 예상됩니다. 무기 의약품 부형제 부문은 2024년 7억 1,630만 달러에서 2029년 말 8억 6,170만 달러로 3.8%의 CAGR로 성장할 것으로 예측됩니다.
세계 의약품 부형제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신흥 기술 및 기술개발 동향, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
의약품의 첨가제의 역할
부형제 기능
제3장 시장 역학
시장 역학 현황
시장 성장 촉진요인
의약품 및 바이오의약품 소비량 증가
기능성 첨가제 수요 증가
신규 첨가제 수요 증가
부형제 즉시 조달
시장 성장 억제요인
높은 개발비
신규 첨가제에 관한 독립한 규제기관의 결여
엄격한 의약품 규제
시장 기회
바이오의약품, 바이오시밀러, 특수 의약품 수요 증가
시장 과제
공급망 혼란
제4장 신기술과 개발
개요
의약품 제제의 3D 프린트
첨가제 선택의 AI
새로운 부형제
임상시험
주요 임상시험
제5장 세계의 의약품 첨가제 시장
세분화 내역
시장 내역 : 재료 유형별
유기 첨가제 : 유형별
무기 첨가제 : 유형별
USP 워터 : 유형별
시장 내역 : 제형별
시장 내역 : 투여 경로별
시장 내역 : 최종사용자별
지역적 내역
시장 내역 : 지역별
북미
유럽
아시아태평양
라틴아메리카
기타 지역
시장 내역 : 제품별
유기 첨가제 : 지역·국가별 시장
무기 첨가제 : 지역·국가별 시장
제6장 경쟁 정보
업계 시나리오
기업 점유율
경쟁 상황
제7장 의약품 첨가제 시장의 지속가능성 : ESG 관점
ESG : 소개
환경 퍼포먼스
사회적 퍼포먼스
거버넌스 퍼포먼스
BCC에 의한 결론
제8장 부록
조사 방법
약어
참고문헌
기업 개요
ADM
ASAHI KASEI CORP.
ASHLAND
BASF SE
CRODA INTERNATIONAL PLC
EVONIK INDUSTRIES AG
INGREDION
KERRY GROUP PLC
ROQUETTE FRERES
ksm
영문 목차
영문목차
The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.
The global market for organic excipients is expected to grow from $8.7 billion in 2024 to $11.2 billion by the end of 2029, at a CAGR of 5.2% from 2024 to 2029.
The global market for inorganic pharmaceutical excipients is expected to grow from $716.3 million in 2024 to $861.7 million by the end of 2029, at a CAGR of 3.8% from 2024 to 2029.
Report Scope
This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.
The market is divided into segments as follows:
By excipient material type:
Organic.
Inorganic.
USP water.
By organic type:
Carbohydrates.
Petrochemicals.
Oleochemicals.
Proteins.
Other organic excipients.
By inorganic type:
Calcium salts.
Halites.
Metal oxides.
Silicates.
Other inorganic excipients.
By dosage form:
Solid dosage form.
Liquid dosage form.
Semisolid dosage form.
Other dosage forms.
By administration route:
Oral.
Injectable.
Topical.
Advanced drug delivery.
By end user:
Pharmaceutical companies.
Contract formulators.
Research institutes.
Other end users.
For each area, for the base year of 2023, BCC Research identified the current products in the market as well as market drivers; measured the current market size; quantified current company market shares; and made forecasts for 2029.
Report Includes
73 data tables and 33 additional tables
An overview of the global market for excipients in pharmaceuticals industry
Analysis of global market trends, featuring historical revenue data from 2021 to 2023, estimated figures for 2024, and projected CAGRs through 2029
Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by material, product type, dosage form, route of administration, end user and region
A look at the innovations, technological advances, clinical trials, and recent product launches
Analysis of the industry's regulatory framework and policies
A discussion of ESG challenges and ESG practices in the industry
An analysis of the key companies' market shares, proprietary technologies, strategic alliances and patents
Profiles of the leading players, including ADM, BASF SE, Roquette Freres, Ashland Global, and Croda International Plc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Role of Excipients in Pharmaceuticals
Functions of Excipients
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Increasing Pharmaceutical and Biopharmaceutical Consumption
Increasing Demand for Functional Excipients
Increasing Demand for Novel Excipients
Instant Sourcing of Excipients
Market Restraints
High Development Costs
Lack of Independent Regulatory Body for Novel Excipients
Stringent Pharmaceutical Regulations
Market Opportunities
Growing Demand for Biologics, Biosimilars and Specialty Drugs
Market Challenges
Supply Chain Disruptions
Chapter 4 Emerging Technologies and Developments
Overview
3D Printing in Drug Formulations
AI in Excipient Selection
Novel Excipients
Clinical Trials
Selected Trials
Chapter 5 Global Market for Pharmaceutical Excipients
Segmentation Breakdown
Market Breakdown by Material Type
Organic Excipients Market, by Type
Market for Inorganic Excipients, by Type
Market for USP Water, by Type
Market Breakdown by Dosage Form
Market Breakdown by Route of Administration
Market Breakdown by End User
Geographic Breakdown
Market Breakdown by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Market Breakdown by Product
Regional and Country-level Markets for Organic Excipients
Regional and Country-level Markets for Inorganic Excipients
Chapter 6 Competitive Intelligence
Industry Scenario
Company Shares
Competitive Landscape
Chapter 7 Sustainability in the Market for Pharmaceutical Excipients: An ESG Perspective